{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:29:12Z","timestamp":1784230152937,"version":"3.55.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ejps.2023.106501","type":"journal-article","created":{"date-parts":[[2023,6,18]],"date-time":"2023-06-18T09:24:36Z","timestamp":1687080276000},"page":"106501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Mucoadhesive 3D printed vaginal ovules to treat endometriosis and fibrotic uterine diseases"],"prefix":"10.1016","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5074-1614","authenticated-orcid":false,"given":"Sarah","family":"Teworte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7190-1605","authenticated-orcid":false,"given":"Simone","family":"Aleandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8094-5260","authenticated-orcid":false,"given":"Marianna","family":"Carone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9664-0149","authenticated-orcid":false,"given":"Paola","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2023.106501_bib0001","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.3390\/molecules26195905","article-title":"Controlled drug delivery systems: current status and future directions","volume":"26","author":"Adepu","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2023.106501_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2004.01.025","article-title":"Why consider vaginal drug administration?","volume":"82","author":"Alexander","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejps.2023.106501_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-89284-3","article-title":"Design aspects of vaginal applicators that influence acceptance among target users","volume":"11","author":"Bakke","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2023.106501_bib0004","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1248\/cpb.59.952","article-title":"In vitro evaluation of mucoadhesive vaginal tablets of antifungal drugs prepared with thiolated polymer and development of a new dissolution technique for vaginal formulations","volume":"59","author":"Baloglu","year":"2011","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejps.2023.106501_bib0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jconrel.2022.01.028","article-title":"How agarose gels surrounding PLGA implants limit swelling and slow down drug release","volume":"343","author":"Bassand","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2023.106501_bib0006","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/03639045.2017.1294600","article-title":"A critical review about methodologies for the analysis of mucoadhesive properties of drug delivery systems","volume":"43","author":"Bassi da Silva","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2023.106501_bib0007","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/humrep\/12.5.1073","article-title":"Targeted drug delivery in gynaecology: the first uterine pass effect","volume":"12","author":"Bulletti","year":"1997","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejps.2023.106501_bib0008","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine fibroids","volume":"369","author":"Bulun","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2023.106501_bib0057","unstructured":"Bunge, K., Hillier S.L., 2023. Safety and Pharmacokinetics of Two Vaginal Film Formulations Containing the Integrase Inhibitor MK-2048. Clinical trail NCT04319718 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04319718."},{"key":"10.1016\/j.ejps.2023.106501_bib0009","first-page":"1","article-title":"A novel nanotechnological mucoadhesive and fast-dissolving film for vaginal delivery of clotrimazole: design, characterization, and in vitro antifungal action","author":"Cervi","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2023.106501_bib0010","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41574-019-0245-z","article-title":"Rethinking mechanisms, diagnosis and management of endometriosis","volume":"15","author":"Chapron","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejps.2023.106501_bib0011","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/humupd\/5.4.365","article-title":"Transvaginal progesterone: evidence for a new functional \u201cportal system\u201d flowing from the vagina to the uterus","volume":"5","author":"Cicinelli","year":"1999","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.ejps.2023.106501_bib0013","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1067\/mob.2003.341","article-title":"Placement of the vaginal 17\u03b2-estradiol tablets in the inner or outer one third of the vagina affects the preferential delivery of 17\u03b2-estradiol toward the uterus or periurethral areas, thereby modifying efficacy and endometrial safety","volume":"189","author":"Cicinelli","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejps.2023.106501_bib0012","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.fertnstert.2003.12.016","article-title":"First uterine pass effect\u201d is observed when estradiol is placed in the upper but not lower third of the vagina","volume":"81","author":"Cicinelli","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejps.2023.106501_bib0014","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.taap.2013.11.021","article-title":"Use of porcine vaginal tissue ex-vivo to model environmental effects on vaginal mucosa to toxic shock syndrome toxin-1","volume":"274","author":"Davis","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2023.106501_bib0015","first-page":"15","article-title":"Recent advances in the excipients used in modified release vaginal formulations","author":"Dedeloudi","year":"2022","journal-title":"Materials"},{"key":"10.1016\/j.ejps.2023.106501_bib0016","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/pharmaceutics12010063","article-title":"3D printing of drug-loaded thermoplastic polyurethane meshes: a potential material for soft tissue reinforcement in vaginal surgery","volume":"12","author":"Dom\u00ednguez-Robles","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2023.106501_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2161-0932.1000422","article-title":"Reduction of Postoperative Adhesions after Laparoscopic Surgery for Endometriosis by Using a Novel Anti-Fibrotic Drug Pirfenidone: a Randomized Double Blind Study","volume":"07","author":"El Halwagy","year":"2017","journal-title":"Gynecol. Obstet."},{"key":"10.1016\/j.ejps.2023.106501_bib0018","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jconrel.2014.04.033","article-title":"Nanoparticle-based drug delivery to the vagina: a review","volume":"190","author":"Ensign","year":"2014","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejps.2023.106501_bib0019","unstructured":"European Medicines Agency. 24\/03\/2023 Esbriet - EMEA\/H\/C\/002154 - II\/0074 https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/esbriet (accessed 19 June 2023)."},{"key":"10.1016\/j.ejps.2023.106501_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-91187-2","article-title":"Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD\/NASH","volume":"11","author":"Escutia-Guti\u00e9rrez","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2023.106501_bib0072","unstructured":"European Directorate for the Quality of Medicines and Healthcare, 2022. European Pharmacopoeia 10.8 1164 Vaginal preparations."},{"key":"10.1016\/j.ejps.2023.106501_bib0054","unstructured":"European Directorate for the Quality of Medicines and Healthcare. 2022. European Pharmacopoeia 10.8. 5.17.1. Recommendations on dissolution testing."},{"key":"10.1016\/j.ejps.2023.106501_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12060568","article-title":"The vaginal-PVPA: a vaginal mucosa-mimicking in vitro permeation tool for evaluation of mucoadhesive formulations","volume":"12","author":"Falavigna","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2023.106501_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120145","article-title":"3D printed estradiol-eluting urogynecological mesh implants: influence of material and mesh geometry on their mechanical properties","volume":"593","author":"Farmer","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106501_bib0024","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s13346-017-0423-2","article-title":"Drug delivery for the treatment of endometriosis and uterine fibroids","volume":"7","author":"Friend","year":"2017","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2023.106501_bib0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpharm.2018.01.036","article-title":"3D printing of vaginal rings with personalized shapes for controlled release of progesterone","volume":"539","author":"Fu","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106501_bib0026","article-title":"Endometriosis: cellular and molecular mechanisms leading to fibrosis","author":"Garcia Garcia","year":"2022","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.ejps.2023.106501_bib0020","unstructured":"Genentech, Inc., 2023. Esbriet Prescribing Information https:\/\/www.esbriethcp.com\/dosing-and-administration\/dosing.html (accessed 19 June 2023)."},{"key":"10.1016\/j.ejps.2023.106501_bib0027","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/humrep\/dey015","article-title":"Fibrogenesis resulting from cyclic bleeding: the Holy Grail of the natural history of ectopic endometrium","volume":"33","author":"Guo","year":"2018","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejps.2023.106501_bib0028","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4236\/pp.2011.24037","article-title":"Design and development of an in vitro assay for evaluation of solid vaginal dosage forms","volume":"02","author":"Gupta","year":"2011","journal-title":"Pharmacol. Pharm."},{"key":"10.1016\/j.ejps.2023.106501_bib0029","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/08941939.2016.1215578","article-title":"Effect of pirfenidone on vascular proliferation, inflammation and fibrosis in an abdominal adhesion rat model","volume":"30","author":"Hasdemir","year":"2017","journal-title":"J. Investig. Surg."},{"key":"10.1016\/j.ejps.2023.106501_bib0030","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2023.106501_bib0031","first-page":"1677","volume":"179","author":"Horne","year":"2019","journal-title":"SnapShot Endometriosis Cell"},{"key":"10.1016\/j.ejps.2023.106501_bib0032","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2004.11.034","article-title":"The vagina as a route for systemic drug delivery","volume":"103","author":"Hussain","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2023.106501_bib0033","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/humupd\/dmx032","article-title":"Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics","volume":"24","author":"Islam","year":"2018","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.ejps.2023.106501_bib0034","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14227\/DT150208P27","article-title":"Proposed design of a dissolution apparatus for vaginal formulations containing probiotics","volume":"15","author":"Kale","year":"2008","journal-title":"Dissolution Technol."},{"key":"10.1016\/j.ejps.2023.106501_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113858","article-title":"Mucosal drug delivery and 3D printing technologies: a focus on special patient populations","author":"Karavasili","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2023.106501_bib0036","series-title":"In Vitro Drug Release Testing of Special Dosage Forms","first-page":"177","article-title":"Vaginal and intrauterine delivery systems vaginal and uterine anatomy and physiology relevant to drug delivery","author":"Klein","year":"2020"},{"key":"10.1016\/j.ejps.2023.106501_bib0037","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/jcem.83.1.4503","article-title":"Pirfenidone: a novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production","volume":"83","author":"Lee","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejps.2023.106501_bib0038","doi-asserted-by":"crossref","first-page":"9467","DOI":"10.1038\/s41598-020-66298-x","article-title":"Dose-dependent pro- or anti-fibrotic responses of endometriotic stromal cells to interleukin-1\u03b2 and tumor necrosis factor \u03b1","volume":"10","author":"Matsuzaki","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2023.106501_bib0039","article-title":"Vaginal epithelial drug delivery","author":"Matteucci","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.ejps.2023.106501_bib0040","first-page":"1","article-title":"Altered differentiation of endometrial mesenchymal stromal fibroblasts is associated with endometriosis susceptibility","volume":"51","author":"McKinnon","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejps.2023.106501_bib0041","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0015-0282(16)56935-0","article-title":"Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study","volume":"62","author":"Miles","year":"1994","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejps.2023.106501_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114293","article-title":"Advances and future perspectives in epithelial drug delivery","volume":"186","author":"Mohammed","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2023.106501_bib0043","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","article-title":"A vaginal fluid simulant","volume":"59","author":"Owen","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.ejps.2023.106501_bib0044","doi-asserted-by":"crossref","unstructured":"R. Palmeira-De-Oliveira, P. Duarte, A. Palmeira-De-Oliveira, J. Das Neves, M.H. Amaral, L. Breitenfeld, J. Martinez-De-Oliveira, Women's experiences, preferences and perceptions regarding vaginal products: results from a cross-sectional web-based survey in Portugal, 10.3109\/13625187.2014.980501. 20 (2015) 259\u2013271. 10.3109\/13625187.2014.980501.","DOI":"10.3109\/13625187.2014.980501"},{"key":"10.1016\/j.ejps.2023.106501_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114133","article-title":"Women's preferences and acceptance for different drug delivery routes and products","volume":"182","author":"Palmeira-de-Oliveira","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2023.106501_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113955","article-title":"Drug delivery strategies for management of women's health issues in the upper genital tract","volume":"177","author":"Patel","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2023.106501_bib0047","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.actbio.2019.08.003","article-title":"3D bioprinted endometrial stem cells on melt electrospun poly \u03b5-caprolactone mesh for pelvic floor application promote anti-inflammatory responses in mice","volume":"97","author":"Paul","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejps.2023.106501_bib0048","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.colsurfb.2017.07.008","article-title":"Novel ex vivo protocol using porcine vagina to assess drug permeation from mucoadhesive and colloidal pharmaceutical systems","volume":"158","author":"Pereira","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejps.2023.106501_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003495","article-title":"Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): a Phase I randomized trial","volume":"18","author":"Politch","year":"2021","journal-title":"PLOS Med."},{"key":"10.1016\/j.ejps.2023.106501_bib0051","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/labinvest.3700669","article-title":"Pathobiology of transforming growth factor \u03b2 in cancer, fibrosis and immunologic disease, and therapeutic considerations","volume":"87","author":"Prud'homme","year":"2007","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ejps.2023.106501_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113990","article-title":"Additive manufacturing in drug delivery: innovative drug product design and opportunities for industrial application","author":"Ragelle","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2023.106501_bib0053","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.contraception.2015.11.008","article-title":"Engineering and characterization of simplified vaginal and seminal fluid simulants","volume":"93","author":"Rastogi","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.ejps.2023.106501_bib0055","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3109\/10837450.2016.1163385","article-title":"Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro\/in vivo evaluation","volume":"22","author":"Ren\u00e7ber","year":"2017","journal-title":"Pharm. Dev. Technol."},{"issue":"20","key":"10.1016\/j.ejps.2023.106501_bib0056","first-page":"1","article-title":"ARID1A-dependent maintenance of H3.3 is required for repressive CHD4-ZMYND8 chromatin interactions at super-enhancers","volume":"201","author":"Reske","year":"2022","journal-title":"BMC Biol."},{"key":"10.1016\/j.ejps.2023.106501_bib0058","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0168-3659(99)00109-1","article-title":"Correlation of two bioadhesion assays: the everted sac technique and the CAHN microbalance","volume":"61","author":"Santos","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2023.106501_bib0059","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/j.cell.2021.04.041","article-title":"Endometriosis: etiology, pathobiology, and therapeutic prospects","volume":"184","author":"Saunders","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ejps.2023.106501_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114543","article-title":"In vitro and ex vivo models for evaluating vaginal drug delivery systems","volume":"191","author":"Shapiro","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2023.106501_bib0061","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107832118","article-title":"Hexavalent sperm-binding IgG antibody released from vaginal film for development of potent on-demand nonhormonal female contraception","volume":"118","author":"Shrestha","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2023.106501_bib0062","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.esxm.2018.04.006","article-title":"Deep dyspareunia and sexual quality of life in women with endometriosis","volume":"6","author":"Shum","year":"2018","journal-title":"Sex. Med."},{"key":"10.1016\/j.ejps.2023.106501_bib0063","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jps.21077","article-title":"Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa","volume":"97","author":"Squier","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106501_bib0064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-83645-8","article-title":"Collagen I triggers directional migration, invasion and matrix remodeling of stroma cells in a 3D spheroid model of endometriosis","volume":"11","author":"Stejskalov\u00e1","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2023.106501_bib0067","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1152\/physiol.00013.2021","article-title":"Uterine fibroids: hiding in plain sight","volume":"37","author":"Stewart","year":"2022","journal-title":"Physiology"},{"key":"10.1016\/j.ejps.2023.106501_bib0066","article-title":"Uterine fibroids","volume":"2","author":"Stewart","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejps.2023.106501_bib0065","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG An Int. J. Obstet. Gynaecol."},{"key":"10.1016\/j.ejps.2023.106501_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118494","article-title":"3D printing of unique water-soluble polymer-based suppository shell for controlled drug release","volume":"568","author":"Tagami","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106501_bib0069","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182929","article-title":"Medication eluting devices for the field of OBGYN (MEDOBGYN): 3D printed biodegradable hormone eluting constructs, a proof of concept study","volume":"12","author":"Tappa","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2023.106501_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/hlca.202200132","article-title":"Endometriosis, the client disease: molecular targets, active principle, and drug delivery systems","volume":"106","author":"Teworte","year":"2023","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.ejps.2023.106501_bib0070","series-title":"Entwicklung Diskriminierender Und Biopr\u00e4diktiver Methoden zur Bestimmung der Wirkstofffreisetzung aus Langwirksamen Kontrazeptiven Darreichungsformen","author":"Tietz","year":"2019"},{"key":"10.1016\/j.ejps.2023.106501_bib0071","unstructured":"United States Pharmacopeial Convention, Inc, 2023. The United States Pharmacopeia. The National Formulary \u3008711\u3009 Dissolution."},{"key":"10.1016\/j.ejps.2023.106501_bib0073","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3390\/pharmaceutics11120676","article-title":"Synergy of phospholipid\u2014drug formulations significantly deactivates profibrogenic human hepatic stellate cells","volume":"11","author":"Valentino","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2023.106501_bib0074","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2005.09.002","article-title":"Porcine vaginal mucosa as an in vitro permeability model for human vaginal mucosa","volume":"305","author":"Van Eyk","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106501_bib0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humrep\/dex354","article-title":"Time to redefine endometriosis including its pro-fibrotic nature","volume":"33","author":"Vigan\u00f2","year":"2018","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejps.2023.106501_bib0076","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jmig.2019.11.011","article-title":"Cellular components contributing to fibrosis in endometriosis: a literature review","volume":"27","author":"Vigan\u00f2","year":"2020","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.ejps.2023.106501_bib0077","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.addr.2021.04.009","article-title":"Vaginal drug delivery approaches for localized management of cervical cancer","volume":"174","author":"Wang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2023.106501_bib0078","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/pharmaceutics6030512","article-title":"Firmness perception influences women's preferences for vaginal suppositories","volume":"6","author":"Zaveri","year":"2014","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2023.106501_bib0079","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0002-9440(10)63030-1","article-title":"Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model","volume":"159","author":"Zeitvogel","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejps.2023.106501_bib0080","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMra1810764","volume":"382","author":"Zondervan","year":"2020","journal-title":"Engl. J. Med."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723001318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723001318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:06:20Z","timestamp":1760529980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098723001318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":80,"alternative-id":["S0928098723001318"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106501","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucoadhesive 3D printed vaginal ovules to treat endometriosis and fibrotic uterine diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106501"}}